Introduction
Kidney transplantation is associated with improved clinical outcomes and quality of life compared to dialysis [1] [2] [3] , so is the preferred method of renal replacement therapy (RRT) for clinically suitable patients. Early transplantation minimises time on dialysis, a factor associated with reduced graft and patient survival.
Early transplant wait-listing increases the probability of transplantation from a deceased donor because the current national kidney allocation scheme [4] prioritises potential transplant recipients who have accrued more time on the waiting list. Therefore, renal centres achieving earlier transplant wait-listing provide their patients with a clinical advantage.
This analysis aims to evaluate whether access to transplant wait-listing and access to transplantation is equitable in the UK. Rates of wait-listing and rates of transplantation after wait-listing were analysed according to patient characteristics. Time from starting RRT to wait-listing was also analysed. Differences between renal centres and between transplanting versus nontransplanting renal centres were analysed, with adjustment for patient characteristics.
Methods

Study population
To identify factors which influence the likelihood of wait-listing for transplantation, an incident RRT cohort was analysed. All adult patients (N = 20,675) starting RRT between 1 January 2011 and 31 December 2013 at renal centres (N = 71) returning data to the UK Renal Registry (UKRR) were considered for inclusion. Patients aged 65 years and over (N = 10,151), patients listed for multi-organ transplants other than kidney and pancreas (N = 33) and patients who were suspended for more than 30 days within 90 days of wait-listing (N = 593) were excluded. The latter exclusion avoided any potential bias from centres that may activate patients on the transplant waiting list and then immediately suspend them before reactivation after medical assessment of a patient's fitness for transplantation. The remaining 9,898 patients were followed until two years after starting RRT (latest 31 December 2015), until they were registered on the waiting list for a kidney transplant alone or kidney and pancreas transplant, or until death, whichever was earliest.
To identify factors which influence the likelihood of transplantation after wait-listing, patients from the above cohort who were wait-listed before 31 December 2014 were identified. These 5,691 patients were followed until two years after wait-listing (latest 31 December 2016), until they received a kidney transplant alone or kidney and pancreas transplant, or until death, whichever was earliest.
Patients transplanted after starting dialysis were assigned to the renal centre recorded by the UKRR as having provided the dialysis. For patients transplanted pre-emptively, there may be instances where the renal centre recorded was the transplanting centre, even when work-up took place in a non-transplanting centre. 
Data analysed
Outcomes
Proportion of incident dialysis patients wait-listed within two years of starting RRT. In addition to patients wait-listed during the study period, patients who received a living donor transplant within two years of starting RRT were also considered to have been wait-listed.
Days from starting RRT to transplant wait-listing. For patients wait-listed after starting dialysis, time from starting dialysis to wait-listing was recorded. Patients receiving a pre-emptive transplant (living or deceased donor) were recorded as wait-listed on the day of transplantation (i.e. time from starting RRT to waitlisting: zero days). Patients who received a living donor transplant after starting dialysis who had not been formally wait-listed prior to transplantation were recorded as wait-listed six months before the date of their transplant (with a minimum time to wait-listing of zero days). This aimed to account for the time needed to prepare patients for a living donor transplant, assuming suitability for wait-listing six months before living donor transplantation.
Proportion of wait-listed patients receiving a transplant within two years of wait-listing. Transplants from donors after brainstem death were considered separately from transplants from donors after circulatory death or living donors, because of differences in the process of allocation. Kidneys from donors after brainstem death are allocated according to national allocation policy, while kidneys from donors after circulatory death are allocated regionally according to the 2006 donor after brainstem death kidney allocation scheme, and one kidney from each donor is offered to the local transplant centre [4] . The process of living donor transplantation is managed by the transplanting centre (and referring nontransplanting centre). The overall proportion transplanted from any donor type was also calculated.
Statistical methods
Logistic regression models were fitted to examine the relationship between patient characteristics (age group, ethnicity, sex, PRD) and transplant wait-listing within two years of starting RRT, or receipt of a transplant within two years of wait-listing. The proportion of all incident RRT patients listed for transplantation within two years of starting RRT and the proportion of wait-listed patients who were transplanted within two years were calculated for each renal centre, with adjustment for the above patient characteristics. Differences in outcome measures between transplanting and non-transplanting renal centres were assessed. Taylor/Robb/Casula/Caskey Median time from starting RRT to wait-listing at each renal centre was estimated by Kaplan-Meier (KM) analysis, censored at death or on 31 December 2015, whichever was earlier. Confidence intervals of median time to wait-listing by centre were derived using bootstrapping. In centres where the KM curve did not reach 50% (and therefore median time could not be calculated), the final event time point was used instead. The effect of renal centre on time to wait-listing was calculated by including renal centre as a covariate in a Cox regression model for time to wait-listing including patients from all centres.
Funnel plots were used to present results for each outcome variable, providing a visual comparison of the relative performance of renal centres. Where appropriate, funnel plots were adjusted for patient characteristics known to influence each outcome, based on the results of the logistic regression models described above. In each funnel plot, the solid thick line indicates the national mean. Dashed lines indicate 95% and 99.8% confidence intervals, corresponding to two and three standard deviations from the mean respectively. Each point on the plot represents one renal centre. For each outcome measure, if no significant inter-centre variation was present, three of 71 renal centres would be expected to fall between the 95% and 99.8% confidence intervals and no centre should fall outside the 99.8% confidence interval. Funnel plots showing the proportion of patients transplanted at two years after wait-listing excluded centres with fewer than ten patients wait-listed at the start of the study period (N = 3). SAS 9.3 was used for all analyses. A p value below 5% was considered statistically significant. The analysis described is based on the methodology described in chapter 11 of the UKRR 17th Annual Report [5] and a previous independently peerreviewed publication [6] .
Results
Access to transplantation by patient characteristics Table 9 .1 shows results of logistic regression analysis for the relationship between patient characteristics and the odds of transplant wait-listing within two years of starting RRT. There were missing ethnicity data for 7.9% of patients and missing PRD data for 4.5%.
The results of logistic regression analyses for the relationship between patient characteristics and the likelihood of receiving a kidney transplant within two years of wait-listing are shown in table 9.2 (donor after brainstem death), table 9.3 (donor after circulatory death or living kidney donor) and table 9.4 (any donor type). Ethnicity data were missing for 7.6% of patients and PRD data for 3.6%.
Access to transplantation by individual renal centre After adjusting for patient characteristics (age, ethnicity, sex, PRD), there were significant differences between renal centres in the proportion of patients wait-listed within two years of starting RRT (figure 9.1, table 9.5).
After adjusting for patient characteristics (age, ethnicity, sex, PRD), there were also significant differences between renal centres in the proportion of patients receiving a kidney transplant within two years of waitlisting. This was true for transplants from donors after brainstem death (figure 9.2, table 9.6) and transplants from donors after circulatory death or living donors (figure 9.3, table 9.6). The number of centres falling on or outside the 99.8% confidence intervals was more marked in the analysis of transplants from donors after circulatory death or living kidney donors, with five falling above and ten centres below. Overall, this equated to a significant inter-centre difference in the proportion of patients receiving a transplant from any donor type within two years of wait-listing (figure 9.4, table 9.6).
Access to transplantation by transplanting vs non-transplanting renal centre
Compared to patients treated at transplanting renal centres, those treated at non-transplanting renal centres:
. Were less likely to be wait-listed within two years of starting dialysis (OR 0.70, 95% CI 0.65-0.77) . Had an equal chance of receiving a transplant from a donor after brainstem death within two years of wait-listing (OR 1.06, 95% CI 0.91-1.23) Taylor/Robb/Casula/Caskey Overall, this equated to a reduced chance of receiving a transplant from any donor type for patients treated at non-transplanting renal centres (OR 0.88, 95% CI 0.78-0.98).
Time to transplant wait-listing by renal centre Table 9 .7 shows the median time (days), or the final event time, from starting RRT to wait-listing for each renal centre. Figure 9 .5 shows a funnel plot of time from starting RRT to wait-listing by renal centre. These values were derived from simulations based on the actual data and for six centres (those with fewer events and/or longer waiting times) median values could not be estimated, so final event times are shown. Taylor/Robb/Casula/Caskey Taylor/Robb/Casula/Caskey
Discussion
Patient characteristics and access to transplantation Increasing patient age was associated with reducing odds of wait-listing and of transplantation from any donor type. This is an expected finding because of the effect of age on the risks and benefits of transplantation: older age is associated with increasing comorbidity and therefore increased clinical risk of transplantation, while the potential benefit of transplantation in extending life reduces with increasing age. Older patients who are suitable for transplantation would be expected to have increased comorbidity and therefore require more screening investigations before being wait-listed, reducing the chance of wait-listing within two years of starting RRT. Reduced odds of receiving a transplant from a donor after brainstem death in older patients reflects the role of age in the national kidney allocation scheme [4] . In analyses adjusted for age, ethnicity and PRD, female sex was associated with a reduced chance of transplant wait-listing within two years of starting RRT (OR 0.83; 95%CI: 0.76-0.90), reduced chance of DCD/living donor transplant within two years of wait-listing (OR 0.88; 95% CI: 0.79-0.98), and reduced chance of any transplant within two years of wait-listing (OR 0.85; 95% CI: 0.76-0.96). As would be expected, there was no significant difference by sex in the odds of transplantation from a donor after brainstem death within two years of wait-listing (OR 0.95; 95% CI: 0.82-1.10). While previous reports have not always shown significant differences in wait-listing or transplantation by sex, when there have been differences, women have been shown to be at a relative disadvantage. This finding needs validating in an extended, multi-year UK cohort with data on comorbidity, but if confirmed clearly needs work to explore possible explanations.
Patients with diabetes as their PRD were less likely to be wait-listed within two years of starting RRT, and less likely to receive a transplant from a donor after circulatory death/living donor within two years of wait-listing. Higher prevalence of comorbidity amongst patients with diabetes may preclude transplantation or lengthen the medical evaluation process, explaining this finding. Patients with diabetes as their PRD were found to be more likely to receive a transplant from a donor after brainstem death once on the waiting list. This is likely to reflect the prioritisation of dual organ transplantation in organ allocation policy, in addition to the increase in the number of simultaneous kidney pancreas transplants during the study period. There was no overall difference by diabetic status in the likelihood of transplantation at two years after wait-listing when all donor types were considered.
As in the 19th Annual Report [7] , non-White ethnicity did not significantly influence the likelihood of waitlisting (OR 1.03; 95% CI: 0.93-1.15). There was a persisting effect of non-White ethnicity in reducing the chance of transplantation from a donor after brainstem death within two years of wait-listing, with a similar magnitude to analysis from 2013-2015 (OR 0.72; 95% CI: 0.60-0.85 compared to OR 0.79; 95% CI: 0.65-0.95) [7] . This effect remained smaller than the one observed on the incident 2008-2010 cohort (OR 0.65; 95% CI: 0.52-0.81) [5] . This may reflect changes in the efficiency of preparation for transplant wait-listing (for instance, earlier completion of pre-transplant investigations for patients with diabetes, who were more likely to have non-White ethnicity), changes in the demographics of potential transplant recipients with non-White ethnicity, and alterations in the national kidney allocation scheme, which now has less strict criteria in relation to human leucocyte antigen (HLA) matching [4] . The latter change means that recipients with non-White ethnicity were less likely to be disadvantaged by the relative lack of organs from non-White donors. There was persisting differences by ethnicity in rates of transplantation from a donor after circulatory death/living donor. It should be noted that differences in socioeconomic status between ethnic groups have previously been found to account for some of the difference in access to transplantation by ethnicity [8, 9] . Lack of adjustment for socioeconomic status therefore limits the reliability of these results. The UKRR is collaborating with the Access to Transplant and Transplant Outcome Measures (ATTOM) study, whose forthcoming results include analyses with detailed adjustment for comorbidity and individual level socioeconomic status.
When interpreting the analyses in this chapter it is also important to consider the potential impact of missing data on the results. Data were missing either because a renal centre failed to complete relevant fields on their renal IT system or from a failure to extract this data. Missing data may not be at random: patients with increased comorbidity are likely to die sooner, allowing inadequate time for their physician to enter relevant comorbidity data. The very process of working up and listing a patient makes it less likely that data will be missing. It is therefore perhaps not surprising that patients on the national kidney transplant waiting list were more likely to have ethnicity and PRD data reported (p , 0.0001) Taylor/Robb/Casula/Caskey
Centre variation in access to transplantation The analyses presented here suggest significant intercentre variation in access to the transplant waiting list and access to transplantation, after adjustment for patient demographics and PRD. However, such results should be interpreted with caution. Adjustment for comorbidity included only diabetes as a PRD. Other comorbidities, unaccounted for in these analyses, may also preclude or delay wait-listing and transplantation. Adjustment for several other factors known to influence access to transplantation, including socioeconomic status, PRD other than diabetes, comorbidity, and HLA sensitisation was not performed. Whilst the processes of wait-listing or transplantation from a donor after circulatory death/living donor are directly influenced by individual centre practice, the allocation of transplants from donors after brainstem death is controlled by the national kidney allocation scheme. Therefore, rates of transplantation from donors after brainstem death should be relatively independent of centre practice differences (except for variation in the acceptance criteria of individual clinicians). As such, the persistence of significant inter-centre variation in rates of transplantation from donors after brainstem death is consistent with under-adjustment for patient factors.
After adjustment for patient characteristics, patients treated at transplanting renal centres had increased access to transplant wait-listing and to transplantation from a donor after circulatory death or living donor. There was no difference in access to transplants from donors after brainstem death once patients were wait-listed. These have been consistent findings in UKRR analyses since 2010, suggesting that reduced contact with clinicians directly involved in transplantation and increased geographical distance to transplanting centres reduces access to transplantation. This analysis may be subject to bias by lack of conclusive adjustment for patient characteristics as well as the allocation of patients receiving a preemptive transplant to their transplanting centre, even if the work-up had been initiated in a timely fashion by the non-transplanting centre. Lastly, there was competition between the two outcome variables (transplant from a donor after brainstem death versus transplant from a donor after circulatory death/living donor). As such, patients from centres with a higher rate of transplantation from a donor after circulatory death/living donor may have reduced odds of transplantation from a donor after brainstem death (and vice versa).
These issues will be addressed in future analyses, allocating patients according to their location of residence (rather than their treatment centre), and using methodology which accounts for competing risk. In addition, the results of analyses from the ATTOM study with more detailed adjustment for case mix are forthcoming.
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